Silvercrest Asset Management Group LLC Neuronetics, Inc. Transaction History

Silvercrest Asset Management Group LLC

$14.1 Billion
Q1 2024

A detailed history of Silvercrest Asset Management Group LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 1,178,365 shares of STIM stock, worth $2.12 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,178,365

Previous 1,126,484 4.61%

Holding current value

$2.12 Million

Previous $3.27 Million 71.74%

% of portfolio

0.04%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.68 - $4.8 $139,041 - $249,028	51,881 Added 4.61%	1,178,365 $5.61 Million
Q3 2023 Nov 14, 2023	SELL	$1.29 - $2.22 $3,800 - $6,540	-2,946 Reduced 0.26%	1,126,484 $1.52 Million
Q2 2023 Aug 14, 2023	BUY	$2.07 - $2.92 $330,038 - $465,561	159,439 Added 16.44%	1,129,430 $2.43 Million
Q1 2023 May 15, 2023	BUY	$2.81 - $6.71 $507,424 - $1.21 Million	180,578 Added 22.87%	969,991 $2.82 Million
Q4 2022 Feb 14, 2023	SELL	$3.44 - $6.87 $23,925 - $47,780	-6,955 Reduced 0.87%	789,413 $5.42 Million

Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $50,929 - $100,991	-21,672 Reduced 2.65%	796,368 $2.53 Million
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $76,094 - $135,077	-36,409 Reduced 4.26%	818,040 $2.63 Million
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $22,365 - $35,595	7,875 Added 0.93%	854,449 $2.59 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $1.16 Million - $1.98 Million	300,651 Added 55.07%	846,574 $3.78 Million
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $77,650 - $194,001	-12,484 Reduced 2.24%	545,923 $3.58 Million
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $946,111 - $1.61 Million	93,213 Added 20.04%	558,407 $8.95 Million
Q1 2021 May 17, 2021	BUY	$10.6 - $21.27 $2.42 Million - $4.85 Million	227,914 Added 96.05%	465,194 $5.75 Million
Q4 2020 Feb 16, 2021	BUY	$4.95 - $11.45 $1.17 Million - $2.72 Million	237,280 New	237,280 $2.64 Million
Q1 2020 May 15, 2020	SELL	$1.28 - $4.5 $365,518 - $1.29 Million	-285,561 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.03 - $9.22 $196,768 - $450,175	-48,826 Reduced 14.6%	285,561 $1.28 Million
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $2.78 Million - $4.36 Million	334,387 New	334,387 $2.78 Million

Others Institutions Holding STIM

# of Institutions

Shares Held

18.4M

Call Options Held

200

Put Options Held

3.6K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $48.6M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Account

Silvercrest Asset Management Group LLC Neuronetics, Inc. Transaction History